Matteo Molica

24PUBLICATIONS
113CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birthEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Feb 21, 2026
Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Silvio Ligia, Giovanni Manfredi Assanto, Tania Soriano

|Feb 11, 2026
Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

Salvatore Perrone, Andrea Corbingi, Calogero Vetro

|Dec 21, 2025
Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.

Deborah Kasmi, Maria Laura Bisegna, Ida Carmosino

|May 14, 2025
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Rexhep Durmo, Stephane Chauvie, Carla Minoia

|Mar 13, 2025
The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network.

Maria Christina Cox, Matteo Caridi, Alexandro Patirelis

Pageof 4

Frequent Collaborators

4 joint publications

Giovanni Manfredi Assanto

4 joint publications

Michele Merli

3 joint publications

Marzia Varettoni

3 joint publications

Luca Arcaini